Clinical Quality Assurance Services

ProPharma offers global Clinical Quality Assurance consulting to ensure inspection readiness and regulatory compliance across pharmaceutical, biologics, and medical device sectors. Our experienced QA professionals deliver end-to-end support—from GCP audits, SOP development, and CAPA management to trial oversight and mock inspections—tailored to your needs in every region. Wherever your clinical programs operate, we help you maintain quality, integrity, and confidence.

smiling-woman-high-fiving-coworker-as-983431523-650x425

Clinical Quality Assurance

A strong Clinical Quality Assurance (CQA) framework is essential for maintaining the integrity, reliability, and compliance of clinical programs. Our CQA services provide proactive to reactive quality support to sponsors and CROs, ensuring adherence to regulatory standards and industry best practices. Ensure Clinical Quality & Compliance with Expert Support.

proactive-reactive-preventative-maintenance-remedial-illustration

Our Clinical Quality Assurance Solutions

Full Service Clinical Trials icon

Vendor Management & Compliance

Oversight and compliance support for CROs, investigator sites, central labs, pharmacies, animal/toxicology studies, SaaS providers, and other vendors to ensure regulatory adherence and performance.

Medical device icon

Clinical Investigation & Remediation

Identifying and resolving clinical trial issues to mitigate risks and improve study outcomes.

Compliance

TMF/eTMF Compliance Reviews

Thorough assessments of Trial Master Files to ensure completeness, accuracy, and regulatory compliance.

Partner icon

Ad-Hoc Clinical Quality Consulting

Tailored support to address specific clinical quality challenges and operational needs.

Comprehensive Clinical Auditing Services

A structured auditing approach is essential for identifying compliance gaps, mitigating risks, and ensuring regulatory readiness. Our clinical auditing services help organizations maintain compliance with global regulatory expectations.

Our Clinical Auditing Solutions

  • Compliance Audits – Conducting audits across GCP, GCLP, GLP, non-GCP, PV, and REMS to ensure adherence to clinical and laboratory standards.
  • Gap Assessments & Mock Inspections – Identifying potential compliance risks and preparing teams for regulatory scrutiny.
  • For-Cause & Due Diligence Audits – Investigating compliance concerns and evaluating potential risks before regulatory action.
  • Vendor & Site Qualification Audits – Assessing CROs, investigators, and sites to ensure they meet regulatory and operational requirements.
Illustration showing the coordination and process for quality audits

Clinical Inspection Readiness

Regulatory inspections can be complex and high-stakes. Our inspection readiness services ensure your organization is fully prepared to meet global regulatory expectations with confidence.

inspection-readiness-workflow-illustration

 

Our Inspection Readiness Solutions

  • Clinical Study Gap Assessment – Identifying and addressing compliance gaps in clinical trials to mitigate regulatory risks.
  • Remediation & Documentation Support – Expert guidance on remediation strategies, including storyboarding, EDC, DMF, SOP development, and CAPA implementation.
  • Inspection Readiness Training – Customized training on regulatory expectations, sponsor responsibilities, and ICH E6 compliance to ensure teams are well-prepared.
  • Mock Regulatory Inspections – Conducting simulated health authority inspections to evaluate and enhance clinical trial readiness.
Healthcare worker and young girl patient smiling together

Clinical Sponsor-Level QMS Support

A well-structured Clinical Sponsor Quality Management System (QMS) is essential for regulatory compliance, operational efficiency, and risk mitigation. At ProPharma, we help sponsors design, implement, and optimize QMS frameworks tailored to their clinical study and organizational needs.

Quality Management System Project Methodology

Preparation

The process begins with a kick-off meeting to ensure alignment with our client and key stakeholders to review unique requirements to consider.

  • The client shares their current business model and organizational objectives.
  • ProPharma reviews the Statement of Work (SOW) to confirm scope and deliverables.
  • Roles, responsibilities, and a communication plan are clearly defined to guide the engagement.

Execution

Moving into the execution phase, we assess and implement QMS improvements:

  • A QMS assessment audit may be recommended to evaluate the current state and identify gaps in compliance.
  • A prioritized GxP documentation implementation plan is developed based on audit findings.
  • Quality system documents are revised or created to address identified needs.
  • Collaborative review sessions and stakeholder interviews are conducted to ensure alignment.
  • Implementation support, including the development of training materials and related documents, is provided as needed.
assess-plan-create-implement-illustration

Our Clinical QMS Consulting Services Include

Global literature review icon

QMS Assessment & Right-Sizing

Evaluating your current QMS and scaling solutions to fit your organization’s size, scope, and regulatory requirements.

Document search icon

Policy & Procedure Development

Creating and refining policies, SOPs, and quality documents to ensure compliance with industry standards.

Adverse event intake icon

End-to-End QMS Implementation

Supporting the seamless integration of quality management systems across your operations.

QPPV office icon

QMS Training & Compliance Readiness

Providing in-depth training on QMS best practices, regulatory expectations, and continuous improvement strategies.

Gradient Image

Optimize Your QMS with Expert Support

Whether you're building a new QMS or enhancing an existing system, our experts provide tailored solutions to ensure compliance and efficiency.

Medical Device Clinical Quality Support

At ProPharma, we provide expert clinical consulting services to medical device and diagnostics companies. Helping to navigate and ensure compliance to complex global regulatory requirements while achieving operational excellence.

Regulatory & Quality Support for Medical Devices

Our team specializes in supporting the unique requirements of medical device companies in meeting international compliance standards, including:

  • Design Control Requirements – Ensuring clinical trial and study activities align with international regulations for product design and development.
  • Clinical Trial File Management – Expert guidance in maintaining regulatory-compliant trial master files.
Woman writing in notebook in a manufacturing facility

Contact Our Clinical Quality Assurance Team

Partner with us for expert clinical compliance and quality solutions. Contact ProPharma today to learn how we can support your organization's Clinical Quality Assurance needs.

News & Insights

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implications

October 28, 2025

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implic...

FDA issues 61 enforcement letters targeting deceptive drug advertising. Explore key trends, efficacy violations, and CCN compliance insights.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implications

October 28, 2025

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implic...

FDA issues 61 enforcement letters targeting deceptive drug advertising. Explore key trends, efficacy violations, and CCN compliance insights.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow